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Abstract 
Aim: To examine the incidence, clinical presentation and risk factors for neurological 
sequelae following childhood community-acquired bacterial meningitis (CABM).  
Methods: We included all children aged 1 month to 15 years old with CABM in North 
Denmark Region, 1998-2016. Using medical records, we registered baseline demographics, 
signs and symptoms at admission, laboratory investigations, and outcome assessed by the 
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Glasgow Outcome Scale (GOS). A GOS score of 1-4 was considered an unfavourable 
outcome. We used modified Poisson regression to examine predefined risk factors for 
neurological sequelae among survivors.  
Results: We identified 88 cases of CABM in 86 patients (45 female) with a median age of 
1.4 years (interquartile range 0.7-4.6). Neisseria meningitidis was the most common 
pathogen (48/88). Neurological sequelae occurred in 23 (27%) as hearing deficits in 13 
(15%), cognitive impairment in 10 (12%), and paresis or sensory deficits in 8 (9%).  
Unfavourable outcome was observed in 16 (18%) patients and three (3%) patients died. 
Abnormalities on cranial imaging remained the only independent risk factor for developing 
neurological sequelae in adjusted analysis.  
Conclusion: Neurological sequelae following CABM in children remain frequent and 
abnormal cranial imaging may be an independent risk factor.  
 
Key notes:  
 In this retrospective population-based cohort study, the risk of neurological sequelae 
following community acquired bacterial meningitis in children remained high (27%) in 
spite of general improvements in medical care. 
 The most frequent sequelae among survivors were hearing deficits (15%) followed by 
cognitive impairment (12%), and motor or sensory deficits (9%). 
 Serious complications diagnosed on cranial imaging may be an independent risk 
factor for long-term neurological sequelae. 
 
Keywords: bacterial meningitis, dexamethasone, long-term sequelae, neurological 
impairment, risk factors. 
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Introduction 
Despite improvements in general medical care, community-acquired bacterial meningitis 
(CABM) in children remains a severe disease with a case fatality rate of 3 to 7% and a high 
risk of neurological sequelae (16-50%) (1-5). The pathophysiology of CABM involves 
inflammation of the blood-brain barrier, loss of vascular autoregulation, increased intracranial 
pressure, and brain oedema (6). This may lead to damage of neurons and ultimately 
neurological deficits (6). Hydrocephalus may result both from impaired resorption of 
cerebrospinal fluid (CSF) by arachnoid villi and obstructed flow at the level of third or fourth 
ventricle (7-9). 
A meta-analysis of outcome following childhood CABM found hearing deficit to be the most 
common neurological sequela (11%) followed by paresis (4%), seizures (4%) and mental 
retardation (4%) (3). The risk of hydrocephalus has been reported to be less than 3% (4). 
The increased risk of long-term developmental, learning and behavioural difficulties may 
eventually result in lower educational achievement and reduced capability of economic self-
sufficiency in adult life (10-12). However, changes in bacterial aetiology after the 
implementation of childhood vaccination programmes and general improvements in medical 
care may have reduced risks of serious complications of childhood CABM. 
Thus, we set out to examine the incidence, clinical characteristics, and pre-defined risk 
factors for neurological sequelae following childhood CABM in North Denmark Region from 
1998 through 2016.  
 
Material and methods  
Setting and study population  
We conducted a retrospective population-based cohort study of children with CABM 
from 1st of January 1998 to 1st of February 2016 in North Denmark Region. Healthcare is tax-
financed in Denmark and free of charge at the point of delivery for all residents. 
The catchment population increased from 493,298 in 1998 to 585,499 inhabitants in the first 
quarter of 2016 mainly due to an administrative reform (13). Throughout the study period, 
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two paediatric departments provided acute care for all children below 15 years of 
age and the Department of Clinical Microbiology at Aalborg University Hospital was 
responsible for all microbiological analyses in the region. The department has also kept track 
of samples sent for supplementary analyses at Statens Serum Institut (Copenhagen). 
Patients with CABM were identified in the laboratory information system (ADBakt, Autonik, 
Sweden) at the Department of Clinical Microbiology.  
Patients were included if they were between 1 month and 15 years of age, had 
symptoms and signs suggesting CABM and ≥ 1 of the following criteria were fulfilled:  
  
1. Positive cerebrospinal fluid (CSF) culture (n=84). 
2. Positive blood culture and one or more of the following CSF findings: > 10 leukocytes/mL; 
CSF:blood glucose ratio< 0.23; CSF glucose < 1.9 mmol/L; protein > 2.2 g/L (n=2). 
3. Detection of bacteria in Gram stain of CSF (n=0).  
4. Non-culture detection of bacteria in CSF by either antigen test or polymerase chain 
reaction for bacterial DNA (n=2). 
  
Only the strongest criterion was noted (1>2>3>4). Exclusion criteria were:  
1. Previous ventriculo-peritoneal (VP) shunt or external ventricular drainage.  
2. Hospital-acquired bacterial meningitis defined by the Centers for Disease Control and 
Prevention (14).  
3. Primary brain abscess.  
 
Brain abscess was categorised as primary if it was diagnosed within the first few days of 
admission and secondary if it developed during admission preceded by cranial imaging 
without brain abscess at admission. 
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Patient Data  
Data collection was performed until December 2016 using all available information in the 
hospital records. We accessed the medical records to obtain information on baseline 
demographics, signs and symptoms at admission and laboratory data. The radiologists’ 
conclusions were used for results of cranial imaging (Table 1). Neuroradiological 
complications were defined as presence of newly acquired hydrocephalus, brain infarction or 
haemorrhage, sinus thrombosis, brain oedema, hygroma, subdural empyema, brain 
herniation, or secondary brain abscess. Patients were categorised according to 
Paediatric Glasgow Coma Scale (PGCS) at admission. However, PGCS was 
often missing in the records and therefore we constructed an estimated PGCS (ePGCS) 
based upon available information: Coma, need for intubation to protect airways (1 point), 
moderately to severely altered mental status, intubation not required (2 points), mildly altered 
mental status (3 points), and normal mental status (4 points).   
For children >2 months of age, dexamethasone was added to the local treatment guideline 
(cefotaxime and penicillin G) in year 2015.  
   
Long-term neurological sequelae were defined as persistent deficits after discharge, 
e.g. hearing deficits with or without cochlear implant, cognitive impairment, motor or sensory 
nerve deficits, hydrocephalus, seizure disorder, and aphasia. Cognitive impairment was 
defined as any patient requiring inter-disciplinary follow-up for learning difficulties, 
behavioural problems, or short-term memory deficits at the Department of Pediatrics. 
Seizure disorder was defined as children registered with seizures or receiving prophylactic 
anti-epileptic drugs during follow-up with exclusion of patients who stopped such treatment 
at first routine outpatient visit after CABM. Follow-up time ranged from 10 months to 16 
years (only one patient had less than 12 months follow-up time).  
We also used the Glasgow Outcome Scale (GOS) to assess outcomes: Death (1 point), 
vegetative state (2 points), severe disability, dependent on others for activities of daily living 
(3 points), moderate disability, independent in daily living but with neurological deficit making 
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the person unable to return to school (4 points), no significant disability and resumption of 
normal daily life (5 points) (15). A GOS score of 1-4 was considered an unfavourable 
outcome.  
 
Statistical analyses 
Categorical variables were described as proportions with percentages and compared with 
Fisher’s exact test due to the low numbers in each cell (16). Continuous variables were 
described as medians with interquartile ranges (IQR) and compared with the Mann-
Whitney’s U-test. A two-tailed p-value< 0.05 was considered statistically significant. We 
computed incidence rates (IRs) with 95% confidence intervals (95% CI) as the annual 
number of cases with CABM divided by the corresponding North Denmark population <15 
years of age by 1st of January each year. Next, we compared incidence rates through the 
study period by direct standardisation using the distribution of children by January 1st 2016 
as reference.  
We used multivariable modified Poisson regression analyses using the robust sandwich 
estimator to examine adjusted relative risks with 95% CIs for predictors of neurological 
sequelae among survivors. The number of events (n=23) restricted the number of variables 
included in the model. Since there was no substantial differences in age or sex of patients 
with neurological sequelae compared with those without such complications, we chose to 
include the following variables based on previous studies and clinical relevance: 
Pneumococcal aetiology (yes/no), neuroradiological complications (yes/no), and adjunctive 
dexamethasone treatment (yes/no) (3,4,17,18,19). STATA MP® version 15.1 was used for 
all for statistical analyses. 
 
Ethical considerations  
The Study was notified to the North Denmark Region in accordance with a directive from the 
Danish Data Protection Agency (2008-58-0028). Approval from the local Ethics Committee 
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or the Danish Board of Health was not required for this type of study in Denmark at the time 
the study was conducted.  
 
Results 
We identified 88 episodes of CABM in 86 children during 1,951,306 person-years of 
observation corresponding to an overall mean standardised incidence rate of 4.39 (95% CI 
2.95-5.83) per 100,000 person-years (Figure 1). The incidence decreased from 5.8 (95% CI 
1.1-10.5) to 1.0 (95% CI 0-2.9) per 100,000 person-years during the study period. The 
median age at diagnosis was 1.4 years (IQR 0.7-4.6) and 45 (51%) were females (Table 1). 
At admission fever was present in 82/87 (94%), neck stiffness in 39/81 (48%), petechiae in 
39/84 (46%), and impaired mental status in 57/88 (65%). Laboratory results showed a 
median C-reactive protein 112 mg/L (IQR 55-206) and a median CSF leukocyte count of 
1,325 106/L (IQR 85-4050). Neisseria meningitidis (55%) and Streptococcus pneumoniae 
(35%) were the most common pathogens followed by Streptococcus agalactiae (5%) (Table 
2).  
Abnormalities on cranial imaging were seen in 11 out of 29 scanned patients (33%). The 
most common findings were hydrocephalus in five, infarction in four, and generalised 
oedema and hygroma in three each. Empiric adjunctive dexamethasone was administered to 
8/88 (9%) patients, and 49/88 (56%) were admitted at the paediatric intensive care unit at 
Aalborg University Hospital. We observed an unfavourable outcome at discharge in 16/88 
(18%) patients and a case fatality rate of 3/88 (3%). 
 
Neurological sequelae occurred in 23 (27%) out of 85 surviving cases with hearing deficit as 
the most common 13/85 (15%) (Table 3). Cognitive impairment (including learning 
difficulties, behavioural problems and short-term memory loss) was found in 10/85 (12%), 
motor or sensory nerve deficits in 8/85 (9%), and seizure disorder in 6/85 (7%). 
Hydrocephalus was diagnosed in 5/85 (6%) and aphasia in 4/85 (5%) patients. A few 
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patients diagnosed with epilepsy stopped prophylactic anti-epileptic drugs during the study 
period without any new seizures registered in the medical records at end of follow-up. 
In univariate analysis of risk of long-term neurological sequelae, we found that predisposing 
infection, abnormal cranial imaging, pneumococcal aetiology, and seizures during admission 
were more frequent among patients with long-term neurological sequelae than among those 
without such complications (Table 4). Similar comparisons in multivariable analyses yielded 
adjusted RRs of 3.49 (95% CI 1.99-6.14) for abnormalities on cranial imaging, 1.66 (95% CI 
0.73-3.79) for pneumococcal aetiology, and 0.84 (95% CI 0.34-2.08) for use of adjunctive 
dexamethasone. 
 
Discussion 
In our study of childhood CABM patients with virtually complete follow-up, we found that 
long-term neurological sequelae occurred in 27% of survivors with hearing deficits as the 
most common sequela. Abnormal cranial imaging, pneumococcal aetiology and seizures 
during admission were more frequent among patients with long-term neurological sequelae 
compared with patients without such complications, but only abnormal cranial imaging 
remained an independent risk factor in multivariable analysis. 
 
Despite general improvements in medical care and decreased case-fatality of childhood 
CABM, risk of long-term neurological sequelae following CABM has not decreased markedly 
over time (20). Compared with our study, a meta-analysis of studies from 1980 to 2008 
reported lower risks of overall long-term neurological sequelae (20% vs. 27%) as well as 
hearing deficits (8% vs. 15%) (4). Of note, meningitis caused by S. pneumoniae was more 
frequent and Haemophilus influenzae less frequent in our cohort than in the meta-analysis 
and differences in their associated prognosis may partly explain these observations (3,4). 
 
 
A
cc
ep
te
d
 A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
In our study, abnormal cranial imaging (any new diagnoses of brain infarction, 
hydrocephalus, abscess, and empyema) was a significant risk factor of neurological 
sequelae in childhood CABM. However, the observed association between abnormal cranial 
MRI and neurological sequelae may partly represent confounding by indication leading to an 
overestimation of measures of risk. Still, the findings consisted of major abnormalities such 
as hydrocephalus, infarction, generalised oedema, hygroma, haemorrhage, cerebral 
herniation, and brain abscess, which are known to cause serious sequelae. Even though a 
large systematic review of published studies of childhood meningitis from 1960 until 2009 did 
not address abnormal cranial imaging as a risk factor (21), our results are in line with other 
recent reports showing an association between brain infarctions or hydrocephalus and 
increased risk of long-term neurological sequelae (17,18).  
 
Pneumococcal aetiology was also associated with an increased risk of long-term 
neurological sequelae in our study, although the width of the 95% CI leaves room for 
interpretation of significance. However, as this association is in accordance with previous 
studies and may be related to bacterial virulence factors, host inflammatory response, and a 
predilection of S. pneumoniae for causing brain infarctions (3,4,17,22,23,24,25) we believe 
that limited sample size is the main reason for this statistical uncertainty. 
The use of adjunctive dexamethasone in childhood CABM is controversial. A Cochrane 
database systematic review of corticosteroids in childhood CABM showed a significant 
reduction in risk of hearing loss in H. influenzae meningitis, while the effect in meningitis 
caused by other pathogens was more uncertain (19). In our study, we did not observe a 
significant association between dexamethasone treatment and improved outcome. However, 
dexamethasone was not implemented before year 2015 in local guidelines for management 
of bacterial meningitis in children above two months of age and only eight patients received 
this treatment in our study.  
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Based on previous studies and our results, we suggest that patients with pneumococcal 
meningitis or abnormalities on cranial imaging should receive careful evaluation during 
follow-up for timely diagnosis of possible neurological sequelae and rehabilitation.  
 
Evaluations of effects of implementation of adjunctive dexamethasone in large contemporary 
cohorts of childhood meningitis are sparse and further improvement in prognosis of bacterial 
meningitis is desperately needed. Although difficult to implement in clinical research at this 
stage, areas of potential interest could be additional anti-inflammatory treatments (26), non-
bacteriolytic antibiotic therapy (27) and management bundles for increased intracranial 
pressure in patients with pneumococcal meningitis (28). 
 
Inherent limitations of the retrospective design of our study include incompleteness of data 
as well as non-standardised diagnostic work-up and room for adjusting treatment by 
attending physicians providing care for the patients. Of relevance, cranial imaging was not 
performed in all patients but important abnormalities would most likely have resulted in 
symptoms requiring further diagnostic examinations during admission or follow-up.  
Outpatient follow-up is paramount for analysing long-term sequelae, and a previous study 
observed spontaneous resolution of neurologic complications within one year following 
childhood CABM (29). In Denmark, all serious complications in children are treated and 
followed in outpatient hospital settings (30), and the long observation period in our study 
enabled us to track and document such serious sequelae. However, some patients may 
have had minor sequelae not affecting cognitive development or everyday physical abilities 
that were cared for by their general practitioner, which would lead to an underestimation of 
the overall proportion with neurological sequelae. 
 
 
 
A
cc
ep
te
d
 A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
In conclusion, we observed a persistent high risk of long-term neurological sequelae among 
survivors of childhood CABM with hearing deficits as the most common sequela. Our results 
suggest that serious complications diagnosed on cranial imaging may be an independent 
risk factor for long-term neurological sequelae. 
 
List of abbreviations: 
CABM = community-acquired bacterial meningitis 
PGCS = paediatric Glasgow Coma Scale  
ePGCS = estimated paediatric Glasgow Coma Scale  
GOS = Glasgow Outcome Scale  
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Table 1: Clinical characteristics at admission of children with community-acquired bacterial 
meningitis in North Denmark Region, 1998-2016. 
 
Characteristics n/N (%) or median (IQR) 
Age, years (median, IQR) (n=88) 1.4 (0.7-4.6) 
Females 45/88 (51) 
Pre-disposing infection* 18/88 (20) 
Duration of symptoms, (days) (n=87) 2 (1-4) 
Headache 22/36 (61) 
Nausea/vomiting 67/74 (91) 
Phono-photophobia 5/73 (7) 
Neck stiffness 39/81 (48) 
Petecchiae 39/84 (46) 
Fever (>37.9°C) 82/87 (94) 
ePGCS 
   1 3/88 (3) 
   2 20/88 (23) 
   3 34/88 (39) 
   4 31/88 (35) 
Motor or sensory nerve deficits 2/37 (5) 
Cranial nerve palsy 3/35 (9) 
Seizures before admission 13/81 (16) 
C-reactive protein (mg/L) (n=88) 112 (55-206) 
B-leukocytes (109/L) (n=88) 18 (12-26) 
Thrombocytes (109/L) (n=81) 306 (201-379) 
P-creatinine (µmol/L) (n=85) 38 (27-52) 
CSF leukocytes (106/L) (n=86) 1325 (85-4050) 
CSF erythrocytes (106/L) (n=83) 70 (15-313) 
CSF glucose (mmol/L) (n=84) 2.6 (0.4-3.9) 
CSF/plasma glucose index (n=79) 0.41 (0.07-0.61) 
CSF protein (g/L) (n=87) 1.1 (0.30-2.0) 
CSF culture detection of pathogen** 86/88 (98) 
Blood culture positive 48/88 (55) 
Cranial imaging during admission 29/88 (33) 
   Cranial imaging abnormalities*** 11/29 (38) 
Adjunctive dexamethasone treatment 8/88 (9) 
Intensive care unit admission 49/88 (56) 
 
ePGCS: estimated paediatric Glasgow Coma Scale. CSF: Cerebrospinal fluid. 
*Acute otitis media in 11, sinusitis in four, pneumonia in three, mastoiditis in none. 
** Includes patients diagnosed by CSF culture (n=84) and by bacterial DNA or antigen 
detection (n=2). 
***Hydrocephalus in five, infarction in four, generalised oedema in three, hygroma in three, 
haemorrhage in two, cerebral herniation and secondary brain abscess in one each. 
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Table 2: Bacterial aetiologies of community-acquired bacterial meningitis in children in North 
Denmark Region, 1998-2016. 
 
Pathogen N=88 (%) 
Neisseria meningitidis 48 (55) 
Streptococcus pneumoniae 31 (35) 
Streptococcus agalactiae (haemolytic group 
B  streptococcus) 
5 (5) 
Haemophilus influenzae 3 (3) 
Listeria monocytogenes 1 (1) 
 
 
Table 3: Outcome of community-acquired bacterial meningitis in children in North Denmark 
Region, 1998-2016. 
 
Outcome N=88 (%) 
Glasgow Outcome Score at discharge 
   1 3 (3) 
   2 0 
   3 5 (6) 
   4 8 (9) 
   5 72 (82) 
Long-term sequelae N=85 (%) 
Overall 23 (27) 
   Hearing deficits 13* (15) 
   Cognitive impairment 10 (12) 
   Motor or sensory nerve deficits 8 (9) 
   Seizure disorder 6 (7) 
   Hydrocephalus 5 (6) 
   Aphasia 4 (5) 
 
*Includes two patients with cochlear implant. Hearing loss was observed among 7/24 (23%) 
of patients with pneumococcal meningitis vs. 6/57 (11%) of other meningitis patients 
(p=0.21). 
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Table 4: Comparison of patients with long-term sequelae vs. patients without long-term 
sequelae among the 85 survivors of community-acquired bacterial meningitis in North 
Denmark Region, 1998-2016. 
 
 Long-term  
sequelae  
(n=23) 
No long-term 
sequelae  
(n=62) 
p-value 
Age (years) 1.0 (0.4-4.0) 1.5 (0.8-6.1) 0.11 
Female 10 (43) 34 (55) 0.47 
Predisposing infection 9 (39) 8 (13) 0.01 
Duration of symptoms 
(days) 
3 (2-4) 2 (1-3) 0.08 
Seizures at admission 4 (17) 9 (15) 0.74 
Impaired mental state 
(ePGCS<4) 
19 (83) 36 (58) 0.04 
Pneumococcal aetiology 14 (61) 16 (26) 0.004 
C- reactive protein (mg/L) 106 (38-209) 116 (61-203) 0.56 
CSF leukocytes (106 /L) 647 (152-2870) 1824 (92-6100) 0.51 
CSF:plasma glucose ratio 0.2 (0.02-0.54) 0.44 (0.18-0.65) 0.11 
CSF protein (g/L) 1.4 (0.8-2.9) 1.1 (0.3-1.8) 0.18 
Dexamethasone 2 (9) 6 (10) 1.00 
Cranial imaging 
performed 
12 (52) 17 (26) 0.04 
Pathological findings on 
cranial imaging (yes/no) 
9 (39) 0 <0.001 
Seizures during admission 11 (48) 14 (23) 0.03 
Intensive care unit 
admission 
15 (65) 31 (50) 0.23 
 
  
A
cc
ep
te
d
 A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Figure 1 legend: 
*Excludes patients 0-30 days of age. 
 
Figure 1: Incidence rates of childhood community-acquired bacterial meningitis in North 
Denmark Region from 1998 through 2016. 
 
 
 
 
 
